Real life study of three years omalizumab in patients with difficult-to-control asthma

Even though there are multiple options for the treatment of asthma, there still exists a fair group of patients with difficult-to-control asthma. We describe for the first time the real-world effects of three-year omalizumab treatment on patients with difficult-to-control asthma, seen in a social se...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Allergologia et immunopathologia Ročník 43; číslo 2; s. 120
Hlavní autori:	López Tiro, J Jesús, Contreras, E Angélica Contreras, del Pozo, M Elena Ramírez, Gómez Vera, J, Larenas Linnemann, D
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Spain 01.03.2015
Predmet:	Adolescent Adult Aged Anti-Asthmatic Agents - therapeutic use Asthma - drug therapy Beclomethasone - therapeutic use Disease Progression Emergency Medical Services Female Humans Immunoglobulin E - immunology Male Mexico Middle Aged Omalizumab - therapeutic use Respiratory Function Tests Time Factors Young Adult Mexico Emergency room Asthmatic crisis Anti-IgE Omalizumab Biological Difficult-to-control asthma Severe asthma Asthma exacerbation Hospitalisation
ISSN:	1578-1267, 1578-1267
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!